Literature DB >> 23097158

Danger-associated molecular patterns (DAMPs) in acute lung injury.

Leslie B Tolle1, Theodore J Standiford.   

Abstract

Danger-associated molecular patterns (DAMPs) are host-derived molecules that can function to regulate the activation of pathogen recognition receptors (PRRs). These molecules play a critical role in modulating the lung injury response. DAMPs originate from multiple sources, including injured and dying cells, the extracellular matrix, or exist as immunomodulatory proteins within the airspace and interstitium. DAMPs can function as either toll-like receptor (TLR) agonists or antagonists, and can modulate both TLR and nod-like receptor (NLR) signalling cascades. Collectively, this diverse group of molecules may represent important therapeutic targets in the prevention and/or treatment of acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS).
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23097158     DOI: 10.1002/path.4124

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  60 in total

1.  Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS.

Authors:  Rachel Z Blumhagen; Brenna R Hedin; Kenneth C Malcolm; Ellen L Burnham; Marc Moss; Edward Abraham; Tristan J Huie; Jerry A Nick; Tasha E Fingerlin; Scott Alper
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-03       Impact factor: 5.464

2.  Protective effect of naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-κB, MMP-9 and up-regulated claudin-5 expression.

Authors:  Xue Bai; Xiangjian Zhang; Linyu Chen; Jian Zhang; Lan Zhang; Xumeng Zhao; Ting Zhao; Yuan Zhao
Journal:  Neurochem Res       Date:  2014-05-20       Impact factor: 3.996

3.  AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation.

Authors:  Soo-Ho Choi; Aaron M Wallace; Dina A Schneider; Elianne Burg; Jungsu Kim; Elena Alekseeva; Niki Dj Ubags; Carlyne D Cool; Longhou Fang; Benjamin T Suratt; Yury I Miller
Journal:  JCI Insight       Date:  2018-08-23

Review 4.  The impact of inflammation on respiratory plasticity.

Authors:  Austin D Hocker; Jennifer A Stokes; Frank L Powell; Adrianne G Huxtable
Journal:  Exp Neurol       Date:  2016-07-27       Impact factor: 5.330

5.  Cysteinyl leukotriene D4 (LTD4) promotes airway epithelial cell inflammation and remodelling.

Authors:  Neeraj Dholia; Gurupreet S Sethi; Amarjit S Naura; Umesh C S Yadav
Journal:  Inflamm Res       Date:  2020-11-02       Impact factor: 4.575

6.  Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolution.

Authors:  Eric S White; Alberto R Mantovani
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

7.  Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.

Authors:  Peter J Smit; Weidun A Guo; Bruce A Davidson; Barbara A Mullan; Jadwiga D Helinski; Paul R Knight
Journal:  J Surg Res       Date:  2014-04-08       Impact factor: 2.192

8.  TREM-1 Attenuates RIPK3-mediated Necroptosis in Hyperoxia-induced Lung Injury in Neonatal Mice.

Authors:  Mansoor Ali Syed; Dilip Shah; Pragnya Das; Sture Andersson; Gloria Pryhuber; Vineet Bhandari
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

9.  Endothelial nitric oxide synthase deficiency influences normal cell cycle progression and apoptosis in trabecular meshwork cells.

Authors:  Qiong Liao; Yan-Ming Huang; Wei Fan; Chan Li; Hong Yang
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

Review 10.  Complement-triggered pathways orchestrate regenerative responses throughout phylogenesis.

Authors:  Dimitrios C Mastellos; Robert A Deangelis; John D Lambris
Journal:  Semin Immunol       Date:  2013-05-17       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.